×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| ZENOTECH LABORATORIES LTD. | 102.32 | 9.90 | 86.39 | 0.16 | 317.0 | 76.2 |
| SANJIVANI PARANTERAL LTD. | 179.28 | 17.31 | 178.92 | 1.41 | 285 | 35.1 |
| NATURAL CAPSULES LTD. | 455.62 | -55.8 | 452.03 | -5.4 | 281 | 36.2 |
Zenotech Laboratories Limited, with Security Code 532039, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.0 | 8.2 | 10.5 | 10.9 | 8.1 | 9.9 | 8.7 | 10.2 | 11.1 | 8.6 |
| Expenses | 5.9 | 5.6 | 6.0 | 5.7 | 6.3 | 6.5 | 7.4 | 7.4 | 7.6 | 7.2 |
| Operating Profit | 4.0 | 2.7 | 4.5 | 5.3 | 1.8 | 3.4 | 1.4 | 2.9 | 3.5 | 1.5 |
| OPM % | 40.36% | 32.17% | 42.77% | 48.1% | 21.78% | 34.66% | 15.86% | 27.91% | 31.85% | 16.88% |
| Other Income | 1.2 | 1.2 | 1.2 | 0.3 | 1.3 | 0.3 | 2.7 | 2.0 | 1.5 | 1.6 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.7 | 1.8 |
| Profit before tax | 3.5 | 2.1 | 3.9 | 3.8 | 1.4 | 2.0 | 1.0 | 2.5 | 3.3 | 1.3 |
| Tax % | 5.3% | -30.1% | -27.4% | -11.6% | -51.9% | -37% | -42.7% | -45.5% | -59.6% | -22.5% |
| Net Profit | 3.7 | 1.4 | 2.8 | 3.4 | 0.7 | 1.3 | 1.3 | 1.7 | 1.2 | 1.0 |
| EPS in Rs | 0.6 | 0.24 | 0.46 | 0.55 | 0.11 | 0.21 | 0.22 | 0.28 | 0 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 11% |
| 3 Years: | 6% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 1% |
| 3 Years: | -41% |
| TTM: | -45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | 5% |
| 1 Year: | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -20% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | 5% |
| 1 Year: | 3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|